ISSN: 2572-4916
+44 1478 350008
Godelieve A Tytgat
Department of Paediatric Oncology, Emma Children Hospital, AMC University of Amsterdam, Netherlands
Dr. Tytgat is the Member of Dutch Cancer oncology Group (DCOG); member of protocol and disease commity for neuroblastoma, DCOG Wilms tumours group, Non-Wilms tumor group, specialised in Renal cell Carcinoma (RCC). She has been invited to write chapter in Pediatric Neuroblastoma: molecular detection of Minimal Residual disease (Janine Stutterheim, Godelieve AM Tytgat and C Ellen van der Schoot. In: Diagnosis, Therapy and Prognosis: Neuroblastoma, ed M.A.Hayat, Springer, 2012), invited to join international consortium, NCI, Bone Marrow Working Group, invited to be member of SIOP scientific Programme Advisory Committee (SPAC)